Measuring and publishing hospital data on achieved health outcomes is becoming routine in many health care systems. League tables of hospital quality – based on post-surgical survival rates, for example - are used to highlight variation in performance across providers. These measures, however, reveal little about the health of the vast majority of patients and may fail to detect important variations in quality.
A new discussion paper from the Centre of Health Economics (CHE), University of York, reports first results from a programme of collaborative research by CHE, Nancy Devlin of the OHE, and David Parkin of NHS South of England. The study, funded by the UK Department of Health, is the first to examine the relationship between hospital costs and patients’ health outcomes.
This post reviews OHE's activities in September 2011 that contributed to advancing thought and stimulating innovative ideas in its three key research areas: financing and delivery of health care, HTA methods and processes, and the economics of the pharmaceutical and life sciences industries.
At the Spanish Health Economics Association (AES) conference in May 2011, OHE’s Ruth Puig Peiró discussed a recent OHE study that reviewed the available literature on variations in medicines’ efficacy and effectiveness across countries.
OHE was awarded a UK Department of Health grant to further develop three aspects of health status indexes. Results of the second of these, advances in Time Trade Off methodology, are reported in this post.
Earlier this month, the first set of data on post operative patient reported outcomes (PROMs) was published by the Department of Health (DH). For the first time, this has provided a patient-based assessment of changes in patients’ health related quality of life following hip replacement. The data also cover surgery on knees, varicose veins and groin hernias.
QALY measures have become important tools in valuing health interventions so that resource allocations can be made. Current methods, however, may not adequately capture QALYs for cancer patients, particularly in the last years of life. This post reviews the issues and suggests next steps.
The EuroQol Group's 27th Scientific Plenary will take place in mid-September. Researchers will report on several exciting developments in the EQ-5D, a measure of self-reported health widely used in research and in the NHS PROMs programme. Professor Nancy Devlin (OHE) and Professor Jan van Busschbach (Erasmus MC) are the joint Scientific Chairs.